证券代码：300451 证券简称：创业慧康 创业慧康科技股份有限公司投资者关系活动记录表 2023-003 投资者关系活动 类别 ☐特定对象调研 ☐分析师会议 ☐媒体采访 业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他（请文字说明其他活动内容） 参与单位名称 及人员姓名 线上参与公司2022年度业绩网上说明会的全体投资者 时间 2023年04月26日 15:00-17:00 地点 公司通过"价值在线"（https://www.ir-online.cn/）采用网络远程的 方式召开业绩说明会 上市公司接待人 员姓名 董事长兼总经理 张吕峥先生 董事兼董事会秘书 胡燕女士 财务负责人 郁燕萍女士 独立董事 谭青女士 投资者关系活 动主要内容介 绍 公司就投资者在本次说明会中提出的问题进行了回复： 1、今天的业绩说明会开始了没？ 您好，今天的业绩说明会将于下午3点开始，谢谢。 2、公司在技术服务上主要有哪些服务，是否可以展开说 明？目前合作客户有哪些？ 您好，公司成立以来始终秉承"创造智慧医卫，服务健康 事业"的企业宗旨，专注于医疗卫生健康信息化的建设、研发 及服务创新，依托"慧康云战略"，构建横向业务发展 ...

Market Position and Competition - The company has maintained a leading position in the healthcare information technology sector, establishing a solid market share and brand image[6]. - The company faces intensified competition due to increasing demand for IT services and the entry of new competitors, which may pose risks to its market position[6]. - The company aims to strengthen its market position by expanding its product line and health service ecosystem, enhancing profitability in response to national policy adjustments and macroeconomic changes[45]. - The company is positioned to benefit from increasing industry orders and the trend of market consolidation towards leading firms[121]. Research and Development - The company plans to increase investment in R&D, human resources, and market research to enhance product development and maintain technological advantages[4]. - The company emphasizes the importance of collaboration with renowned universities and research institutions to develop new products and maintain a strong technical foundation[4]. - The company has developed over 300 proprietary products and holds more than 30 invention patents and around 900 software copyrights, demonstrating strong R&D capabilities[69]. - The company’s R&D department follows the CMMI5 software maturity development process, ensuring high-quality control and product testing throughout the development cycle[135]. Financial Performance - The company’s operating revenue for 2022 was ¥1,527,138,670.24, a decrease of 19.58% compared to ¥1,898,976,983.54 in 2021[112]. - The net profit attributable to shareholders for 2022 was ¥42,637,972.84, down 89.68% from ¥413,039,235.38 in 2021[112]. - The net profit after deducting non-recurring gains and losses was ¥46,863,629.56, a decline of 87.90% from ¥387,332,119.99 in 2021[112]. - The basic earnings per share for 2022 was ¥0.03, down 88.89% from ¥0.27 in 2021[112]. Product and Service Development - The company is expanding its business into areas such as smart healthcare, internet medical services, and health big data, which requires effective implementation strategies[16]. - The company has launched a comprehensive IoT access solution for hospitals, addressing the challenges of managing diverse protocols and devices, thereby reducing maintenance difficulties and costs[59]. - The company has developed a smart IoT support platform, creating a service system that includes convenience services, clinical applications, operational management, and health services[54]. - The company is focusing on integrating new technologies such as IoT and big data into hospital systems to improve patient-centered care models[60]. Strategic Initiatives - The company is actively pursuing a "Cloud Strategy" to enhance customer satisfaction and deliver on existing orders, focusing on a patient-centered healthcare system[35]. - The company is committed to enhancing the operational efficiency of healthcare institutions through cloud-based maintenance services and intelligent terminal integration[59]. - The company is committed to becoming a leader in the "Healthy China" initiative, aligning its strategies with national health policies and technological advancements[109]. - The company is exploring innovative applications in traditional Chinese medicine through an internet cloud clinic project, providing online appointment and consultation services[88]. Client and Market Engagement - The company’s main clients are public hospitals and health management departments, with project acceptance and payment concentrated in the second half of the year, particularly in Q4[7]. - The company has established 11 regional marketing service centers and 15 provincial marketing service centers, ensuring timely communication and localized services for clients across 30 provinces[70]. - The company has implemented nearly 20,000 healthcare information projects, serving over 7,000 industry users and covering more than 370 districts nationwide, accumulating approximately 300 million resident health records[68]. - The company has established partnerships with 15 internet hospitals in Zhongshan, including 4 top-tier hospitals, to provide convenient online medical services[179]. Technology Integration and Innovation - The company is developing a comprehensive medical IoT application framework, supporting 5G network applications and various IoT transmission protocols[178]. - The company has successfully launched the first fully cloud-based hospital information system solution for a major medical group in Zhejiang, supporting an average daily outpatient volume of nearly 20,000 patients and over 4,000 total beds[157]. - The company has integrated its intelligent medical services into various internet hospitals and health city applications, providing smart consultation and guidance services[167]. - The company is actively involved in building data service platforms to improve real-time monitoring and efficiency of healthcare services[104]. Regulatory and Policy Environment - The company acknowledges the risk of talent loss and rising human resource costs due to intensified market competition, which could impact its operational performance[19]. - The company’s future business operations may face uncertainties due to potential changes in national policy and macroeconomic conditions[21]. - The government emphasizes the development of smart healthcare and encourages the integration of emerging technologies like AI, big data, and 5G into medical services[127]. - The integration of health data and the establishment of a comprehensive health information system are key tasks outlined for the next five years[127].

证券代码：300451 证券简称：创业慧康 公告编号：2023-017 创业慧康科技股份有限公司 关于举行 2022 年度业绩网上说明会的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 15 日在 巨潮资讯网披露了《2022 年年度报告》及《2022 年年度报告摘要》。为便于广 大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2023 年 4 月 26 日（星期三）15:00-17:00 在"价值在线"（www.ir-online.cn）举办 2022 年度业绩说明会，与投资者进行沟通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 投 资 者 可 于 2023 年 4 月 26 日 （ 星 期 三 ） 15:00-17:00 通过网址 https://eseb.cn/13GibIYbQas 或使用微信扫一扫以下小程序码即可进入参与互动 交流。投资者可于 2023 年 4 月 26 日前进行访问，打开互动交流进行会前提问， 公司将通过本次业绩说明会 ...

证券代码：300451 证券简称：创业软件 编号：2015-01 | --- | --- | --- | |-----------------------|-------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | █ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 华泰证券 孙阳冉，财通证券 章昊秋 吴杭，上海东岭投资 王 | | 人员姓名 | | 顺欢，中银国际 宋彬 宋方云，上海世诚投资 彭希曦，国联 | | | | 安基金 徐岩，杭州泛瑞 盖伟伟 ，华创证券 侯子超 | | 时间 | 2015 年 7 月 30 | 日 | | 地点 | 公司五楼会议室 | | | 上市公司接待人 员姓名 | | 董秘 董祖琰、证代 胡燕、证券法务部副主任 徐胜 | 创业软件股份有限公 ...

证券代码：300451 证券简称：创业软件 创业软件股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|--------------------------------|----------------------------------------------------------| | | | | | 投资者关系活动 | █ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 平安资管、安信证券、东北证券、上海敦孚投资、上银基金、广 | | 人员姓名 | | 发证券、浙商保险、金元顺安基金、沃珑港投资、平安养老、敦 | | | | 和资管、源乐晟资产、海富通基金、国信证券、齐鲁证券、东吴 | | | 证券、华夏基金、北京高华证券等 | | | 时间 | 2015 年 10 月 22 | 日 | | 地点 | 公司三楼会议室 | | | 上市公司接待人 | 董祖 ...

证券代码：300451 证券简称：创业软件 创业软件股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------|--------------------------------|------------------------------------------------------------| | | | | | 投资者关系活动 | █ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 光大证券、现成资产、上海承周资产、嘉实基金、大成基金、交 | | 人员姓名 | | 银施罗德基金、国泰基金、东方证券、合正致淳、光大保德信基 | | | | 金、丰联金融、建信基金、毅木资产、东方证券、上投摩根基金、 | | | | 明尚投资、睿泉资本、广发基金、博士基金、嘉宏基金、国海证 | | | 券、深圳民森投资 | | | 时间 | 2015 年 9 月 24 | 日 ...

编号：2020-002 证券代码：300451 证券简称：创业慧康 创业慧康科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...